Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release

Psychopharmacology (Berl). 1998 Mar;136(2):198-200. doi: 10.1007/s002130050556.

Abstract

The prolactin responses to the serotonin (5-HT) releasing agent d-fenfluramine (30 mg orally) were studied in 11 male normal volunteers after administration of hydrocortisone (20 mg orally, twice daily for 10 days) using a double-blind, placebo-controlled, cross-over design. While hydrocortisone treatment significantly elevated 24-h urinary cortisol excretion, it did not lower the prolactin response to d-fenfluramine. Plasma levels of d-fenfluramine and d-norfenfluramine were not altered by hydrocortisone treatment. These findings show that following 10 days administration of hydrocortisone, the prolactin responses to d-fenfluramine are not changed.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / pharmacology*
  • Fenfluramine / pharmacology*
  • Humans
  • Hydrocortisone / pharmacology*
  • Male
  • Prolactin / blood*
  • Selective Serotonin Reuptake Inhibitors / pharmacology*

Substances

  • Anti-Inflammatory Agents
  • Serotonin Uptake Inhibitors
  • Fenfluramine
  • Prolactin
  • Hydrocortisone